Virtu Financial LLC Bria Cell Therapeutics Corp. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$4.28 - $6.73 $120,199 - $189,005	-28,084 Reduced 58.09%	20,263 $89,000
Q3 2022 Nov 07, 2022	BUY	$3.0 - $8.31 $113,682 - $314,899	37,894 Added 362.52%	48,347 $272,000
Q2 2022 Aug 09, 2022	BUY	$4.28 - $11.9 $44,738 - $124,390	10,453 New	10,453 $60,000
Q1 2022 May 17, 2022	SELL	$5.91 - $10.14 $147,614 - $253,266	-24,977 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$7.1 - $10.61 $56,622 - $84,614	-7,975 Reduced 24.2%	24,977 $207,000
Q3 2021 Nov 12, 2021	BUY	$4.4 - $9.28 $144,988 - $305,794	32,952 New	32,952 $267,000
Q2 2021 Sep 17, 2021	SELL	$2.89 - $6.57 $43,699 - $99,344	-15,121 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$3.15 - $6.17 $47,631 - $93,296	15,121 New	15,121 $58,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $9.31M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.